High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study

被引:25
作者
Bi, Chao [1 ,2 ]
Liu, Mei [2 ,3 ,4 ]
Rong, Weiqi [1 ,2 ]
Wu, Fan [1 ,2 ]
Zhang, Yang [1 ,2 ]
Lin, Shengtao [1 ,2 ]
Liu, Yunhe [1 ,2 ]
Wu, Jianxiong [1 ,2 ]
Wang, Liming [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Dept Hepatobiliary Surg, Natl Clin Res Ctr Canc, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[2] Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Lab Cell & Mol Biol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[4] Chinese Acad Med Sci, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
关键词
Intrahepatic cholangiocarcinoma; Beclin-1; ARIDIA; IDH1; CA9; CARBONIC-ANHYDRASE-IX; STAGING SYSTEM; PROGNOSTIC-SIGNIFICANCE; DECREASED EXPRESSION; IDH2; MUTATIONS; UNITED-STATES; BILIARY-TRACT; LIVER-CANCER; AUTOPHAGY; MODULATION;
D O I
10.1186/s12885-019-5429-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundAlthough surgical resection provides a cure for patients with intrahepatic cholangiocarcinoma (ICC), the risk of mortality and recurrence remains high. Several biomarkers are reported to be associated with the prognosis of ICC, including Beclin-1, ARID1A, carbonic anhydrase IX (CA9) and isocitrate dehydrogenase 1 (IDH1), but results are inconsistent. Therefore, a histopathological retrospective study was performed to simultaneously investigate the relationship of these four potential biomarkers with clinicopathological parameters and their prognostic values in patients with ICC.MethodsA total of 113 patients with ICC were enrolled from Cancer Hospital of Chinese Academy of Medical Sciences between January 1999 and June 2015. The expression of Beclin-1, ARID1A, IDH1 and CA9 were determined by immunohistochemical staining. The prognostic values of the four biomarkers were analyzed by Cox regression and the Kaplan-Meier method.ResultsBeclin-1, ARID1A, CA9 and IDH1 were highly expressed in ICC tumor tissues. Higher mortality was positively associated with Beclin-1 expression (HR=2.39, 95% CI=1.09-5.24) and higher recurrence was positively associated with ARID1A expression (HR=1.71, 95% CI=1.06-2.78). Neither CA9 nor IDH1 expression was significantly associated with mortality or disease recurrence. Kaplan-Meier survival curves showed that ICC patients with higher Beclin-1 and ARID1A expression had a lower survival rate and a worse recurrence rate than patients with low Beclin-1 and ARID1A expression (p<0.05).ConclusionsHigh Beclin-1 and ARIDIA expression are strongly associated with poor prognosis in ICC patients, and thus Beclin-1 and ARID1A should be simultaneously considered as potential prognostic biomarkers for ICC patients.
引用
收藏
页数:11
相关论文
共 64 条
  • [1] Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight
    Al-Khallaf, Hamoud
    [J]. CELL AND BIOSCIENCE, 2017, 7
  • [2] IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
    Amary, M. Fernanda
    Bacsi, Krisztian
    Maggiani, Francesca
    Damato, Stephen
    Halai, Dina
    Berisha, Fitim
    Pollock, Robin
    O'Donnell, Paul
    Grigoriadis, Anita
    Diss, Tim
    Eskandarpour, Malihe
    Presneau, Nadege
    Hogendoorn, Pancras C. W.
    Futreal, Andrew
    Tirabosco, Roberto
    Flanagan, Adrienne M.
    [J]. JOURNAL OF PATHOLOGY, 2011, 224 (03) : 334 - 343
  • [3] Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
    Borger, Darrell R.
    Tanabe, Kenneth K.
    Fan, Kenneth C.
    Lopez, Hector U.
    Fantin, Valeria R.
    Straley, Kimberly S.
    Schenkein, David P.
    Hezel, Aram F.
    Ancukiewicz, Marek
    Liebman, Hannah M.
    Kwak, Eunice L.
    Clark, Jeffrey W.
    Ryan, David P.
    Deshpande, Vikram
    Dias-Santagata, Dora
    Ellisen, Leif W.
    Zhu, Andrew X.
    Iafrate, A. John
    [J]. ONCOLOGIST, 2012, 17 (01) : 72 - 79
  • [4] Prognostic molecular markers in cholangiocarcinoma: A systematic review
    Briggs, Christopher D.
    Neal, Christopher P.
    Mann, Christopher D.
    Steward, William P.
    Manson, Margaret M.
    Berry, David P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 33 - 47
  • [5] Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation
    Carew, Jennifer S.
    Medina, Ernest C.
    Esquivel, Juan A., II
    Mahalingam, Devalingam
    Swords, Ronan
    Kelly, Kevin
    Zhang, Hui
    Huang, Peng
    Mita, Alain C.
    Mita, Monica M.
    Giles, Francis J.
    Nawrocki, Steffan T.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (10) : 2448 - 2459
  • [6] Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer
    Choschzick, Matthias
    Oosterwijk, Egbert
    Mueller, Volkmar
    Woelber, Linn
    Simon, Ronald
    Moch, Holger
    Tennstedt, Pierre
    [J]. VIRCHOWS ARCHIV, 2011, 459 (02) : 193 - 200
  • [7] Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
    Churi, Chaitanya R.
    Shroff, Rachna
    Wang, Ying
    Rashid, Asif
    Kang, HyunSeon C.
    Weatherly, Jacqueline
    Zuo, Mingxin
    Zinner, Ralph
    Hong, David
    Meric-Bernstam, Funda
    Janku, Filip
    Crane, Christopher H.
    Mishra, Lopa
    Vauthey, Jean-Nicholas
    Wolff, Robert A.
    Mills, Gordon
    Javle, Milind
    [J]. PLOS ONE, 2014, 9 (12):
  • [8] Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
    Degenhardt, Kurt
    Mathew, Robin
    Beaudoin, Brian
    Bray, Kevin
    Anderson, Diana
    Chen, Guanghua
    Mukherjee, Chandreyee
    Shi, Yufang
    Gelinas, Celine
    Fan, Yongjun
    Nelson, Deirdre A.
    Jin, Shengkan
    White, Eileen
    [J]. CANCER CELL, 2006, 10 (01) : 51 - 64
  • [9] Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma
    Dong, Li-Wei
    Hou, Yu-Jie
    Tan, Ye-Xiong
    Tang, Liang
    Pan, Yu-Fei
    Wang, Min
    Wang, Hong-Yang
    [J]. AUTOPHAGY, 2011, 7 (10) : 1222 - 1229
  • [10] Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas
    Driessen, A
    Landuyt, W
    Pastorekova, S
    Moons, J
    Goethals, L
    Haustermans, K
    Nafteux, P
    Penninckx, F
    Geboes, K
    Lerut, T
    Ectors, N
    [J]. ANNALS OF SURGERY, 2006, 243 (03) : 334 - 340